Sean P. Gramling

Array ( [id] => 3061129 [patent_doc_number] => 05352449 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-04 [patent_title] => 'Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant' [patent_app_type] => 1 [patent_app_number] => 7/869082 [patent_app_country] => US [patent_app_date] => 1992-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 32 [patent_no_of_words] => 8410 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/352/05352449.pdf [firstpage_image] =>[orig_patent_app_number] => 869082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3010098 [patent_doc_number] => 05331109 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-19 [patent_title] => 'Phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels' [patent_app_type] => 1 [patent_app_number] => 7/864104 [patent_app_country] => US [patent_app_date] => 1992-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3765 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/331/05331109.pdf [firstpage_image] =>[orig_patent_app_number] => 864104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3492373 [patent_doc_number] => 05470997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels' [patent_app_type] => 1 [patent_app_number] => 7/864108 [patent_app_country] => US [patent_app_date] => 1992-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5873 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470997.pdf [firstpage_image] =>[orig_patent_app_number] => 864108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3446774 [patent_doc_number] => 05387578 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-07 [patent_title] => 'New linker for bioactive agents' [patent_app_type] => 1 [patent_app_number] => 7/842171 [patent_app_country] => US [patent_app_date] => 1992-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8714 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/387/05387578.pdf [firstpage_image] =>[orig_patent_app_number] => 842171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2971792 [patent_doc_number] => 05182107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-26 [patent_title] => 'Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates' [patent_app_type] => 1 [patent_app_number] => 7/846830 [patent_app_country] => US [patent_app_date] => 1992-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 12017 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/182/05182107.pdf [firstpage_image] =>[orig_patent_app_number] => 846830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3456504 [patent_doc_number] => 05378815 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-03 [patent_title] => 'Process for indirect targeted immunocytolysis' [patent_app_type] => 1 [patent_app_number] => 7/872966 [patent_app_country] => US [patent_app_date] => 1992-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5235 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/378/05378815.pdf [firstpage_image] =>[orig_patent_app_number] => 872966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2898338 [patent_doc_number] => 05217881 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-08 [patent_title] => 'Hyperglycosylated cytokine conjugates' [patent_app_type] => 1 [patent_app_number] => 7/827517 [patent_app_country] => US [patent_app_date] => 1992-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6493 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/217/05217881.pdf [firstpage_image] =>[orig_patent_app_number] => 827517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3003613 [patent_doc_number] => 05354554 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-10-11 [patent_title] => 'Crosslinked antibodies and processes for their preparation' [patent_app_type] => 1 [patent_app_number] => 7/824867 [patent_app_country] => US [patent_app_date] => 1992-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6100 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/354/05354554.pdf [firstpage_image] =>[orig_patent_app_number] => 824867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2976867 [patent_doc_number] => 05208323 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-04 [patent_title] => 'Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent' [patent_app_type] => 1 [patent_app_number] => 7/819669 [patent_app_country] => US [patent_app_date] => 1992-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2942 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/208/05208323.pdf [firstpage_image] =>[orig_patent_app_number] => 819669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3073825 [patent_doc_number] => 05360897 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-01 [patent_title] => 'Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad' [patent_app_type] => 1 [patent_app_number] => 7/819305 [patent_app_country] => US [patent_app_date] => 1992-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10978 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/360/05360897.pdf [firstpage_image] =>[orig_patent_app_number] => 819305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3458354 [patent_doc_number] => 05441867 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-08-15 [patent_title] => 'Pre-activated proteins for labelling oligonucleotide probes' [patent_app_type] => 1 [patent_app_number] => 7/815881 [patent_app_country] => US [patent_app_date] => 1992-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 4967 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/441/05441867.pdf [firstpage_image] =>[orig_patent_app_number] => 815881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2957112 [patent_doc_number] => 05273743 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-12-28 [patent_title] => 'Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent' [patent_app_type] => 1 [patent_app_number] => 7/808193 [patent_app_country] => US [patent_app_date] => 1991-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16180 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/273/05273743.pdf [firstpage_image] =>[orig_patent_app_number] => 808193 [rel_patent_id] =>[rel_patent_doc_number] =>)